期刊文献+

急性缺血性脑血管病病人血浆溶血磷脂酸水平的变化 被引量:5

下载PDF
导出
摘要 目的探讨急性缺血性脑血管疾病病人血浆溶血磷脂酸(LPA)水平的变化。方法选择189例急性缺血性脑血管疾病病人,根据病情将其分为脑梗死组103例、短暂性脑缺血组86例,并选择95例查体健康者作为正常对照组,分别测定其血浆LPA水平。结果脑梗死组血浆LPA为(3.10±1.42)μmol/L,短暂性脑缺血组为(3.04±1.29)μmol/L,均明显高于正常对照组(1.95±0.14)μmol/L;其中异常增高率脑梗死组为67.0%,短暂性脑缺血组为44.2%,正常组为3.2%,脑梗死组、短暂性脑缺血组在进行抗凝、抗血小板聚集治疗后,LPA明显下降。结论血浆LPA作为体内凝血和血栓形成过程早期释放的酶标记物,在预测急性缺血性脑血管病发生、发展及指导合理应用抗凝抗血小板药物及治疗效果评价等方面,有一定应用前景。
出处 《中西医结合心脑血管病杂志》 2005年第7期600-601,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献5

  • 1Moolenaar W H.Lysoptidiv acid a midtifunctional phosphdipid messenger[J].Biol Chem,1995,270:12949-12952.
  • 2中华神经科学会 中华神经外科学会.各类脑血管病诊断要点[J].中华神经科杂志,1996,6:379-379.
  • 3Gueguen G,Gaige B,Grevy J M,et al.Structure-activity analysis of the effects of lysophosphatidi acid on platelet aggregation[J].Bioche Mistry,1999,38:8400-8450.
  • 4孙玉衡,伍期专,姚存姗,黄世昌,唐朝枢,李振光,包鹤丘,李松,周伟仅.缺血性脑卒中患者血浆溶血磷脂酸水平的初步研究[J].中华医学杂志,2002,82(4):229-231. 被引量:106
  • 5Siess W,Zangl Kj,Essler M,et al.Lysophosphatidic acid mediats the rapid activation of platelet and endothelied cells by mildly oxidized low density lipoprotein and accumulated in human atherosclerotic lesions[J].Proc Natl Acad Sci USA,1999,96(12):6931-6693.

二级参考文献12

  • 1Moolenaar WH. Lysophosphatidic acid,a multifunctional phospholipid messenger. J Biol Chem,1995, 270: 12949-12952.
  • 2Tokumura A, Iimori M, Nishioka Y, et al. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol,1994, 267: C204-210.
  • 3Jalink K, Hordijk PL, Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim Biophys Acta,1994, 1198: 185-196.
  • 4Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers JAMA, 1998,280: 719-723.
  • 5Eichholtz T,Jalink K,Fahrenfort I,et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J,1993, 291 : 677-680.
  • 6Torti M, Tolnai Festetics E, Bertoni A, et al. Activation of human platelets by lysophosphatidic acid. Blood Coagul Fibrinolysis,1996,7: 253-255.
  • 7Zhang J, Rittenhouse SE. Lysophosphatidic acid activates phosphoinositide 3-kinase and phospholipase C in human platelets: inhibitory effects of wortmannin on phosphoinositide 3-kinase and aggregation. Biochem Biophys Res Commun,1995, 211: 484-490.
  • 8Gueguen G, Gaige B, Grevy JM,et al. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry,1999,38: 8440-8450.
  • 9Gerrard JM, Robinson P.Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta, 1989, 1001: 282-285
  • 10Gerrard JM,Robinson P,Narvey M,et al. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation,Biochem Cell Biol,1993, 71: 432-439.

共引文献934

同被引文献73

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部